Page last updated: 2024-08-24

triazoles and Neutropenia

triazoles has been researched along with Neutropenia in 165 studies

Research

Studies (165)

TimeframeStudies, this research(%)All Research%
pre-19901 (0.61)18.7374
1990's10 (6.06)18.2507
2000's80 (48.48)29.6817
2010's71 (43.03)24.3611
2020's3 (1.82)2.80

Authors

AuthorsStudies
Moncada, D; Ramírez, I1
Chen, SC; Cornely, OA; Hoenigl, M; Jenks, JD; Thompson, GR1
Gormley, NJ; Kasamon, YL; Li, RJ; Ma, L; Okusanya, OO; Pazdur, R; Price, LSL; Richardson, NC; Theoret, M; Wu, YT1
Ai, H; Chen, J; Han, M; Hu, J; Huang, H; Huang, X; Ji, Y; Liang, Y; Ma, J; Meng, F; Tang, Y; Wu, D; Zhang, R; Zhang, X1
Ho, CL; Lee, CH; Lin, C; Lin, JC; Sun, M; Yen, WT1
Feng, S; Han, M; He, Y; Jiang, E; Liu, L; Wang, Z; Wei, J; Yang, D; Zhai, W; Zhang, G; Zhang, L; Zhang, R; Zhang, S1
Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A1
Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Hope, W; Kontoyiannis, DP; Lademacher, C; Lortholary, O; Mullane, K; Patterson, TF; Selleslag, D1
Berman, E; Epstein, DJ; Frattini, MG; Huang, YT; Klimek, VM; Papanicolaou, GA; Park, JH; Seo, SK; Tallman, MS1
Ho, CL; Lee, CH; Lin, C; Lin, JC1
Arrieta, AC; Bradley, JS; Carmelitano, P; Gates, D; Groll, AH; Joshi, A; Kartsonis, NA; Lehrnbecher, T; Mangin, E; Paschke, A; Sung, L; Walsh, TJ; Waskin, H; Zwaan, CM1
Athanasakis, K; Kyriopoulos, J; Petrakis, I1
Gao, Y; Ping, B; Wu, B; Yue, C; Zhu, Y1
Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC1
De la Serna, J; Fernández-Navarro, JM; Gómez, V; Jarque, I; Jurado, M; López-Jiménez, J; Pascual, A; Romero, M; Serrano, J; Vallejo, C1
Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z1
Labbadia, F; Sanchez-Salinas, A1
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M1
Gamaletsou, MN; Walsh, TJ1
Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Jain, MR; Krel, M; Li, H; Perlin, DS; Petraitiene, R; Petraitis, V; Walsh, TJ; Zhao, Y1
Bangard, C; Cornely, OA; Shimabukuro-Vornhagen, A; Tran, L; Vehreschild, JJ; Vehreschild, MJ; von Bergwelt-Baildon, M; Wisplinghoff, H1
Åkerborg, Ö; Björkholm, M; Höglund, M; Lundberg, J1
Akkapeddi, P; Haldar, J; Manjunath, GB; Yarlagadda, V1
Morris, AM1
Chandrasekar, P; Connelly, N; Cornely, OA; Duarte, RF; Haider, S; Helfgott, D; Kartsonis, N; Langston, A; Laverdiere, M; López-Jiménez, J; Ma, L; Perfect, J; van Iersel, ML; Waskin, H1
Albert, ND; Kontoyiannis, DP; Lewis, RE1
Böhme, A; Cornely, OA; Schmitt-Hoffmann, A; Ullmann, AJ1
Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Handgretinger, R; Hartmann, U; Müller, I; Schulz, A; Schwarze, CP1
Han, M; Huang, H; Huang, X; Ji, Y; Meng, F; Ren, H; Shen, Z; Sun, Y; Wang, C; Wu, D; Yu, L; Zhang, X1
Arilla, MJ; Boluda, B; Calvillo, P; Cano, I; Carpio, N; Jarque, I; Lancharro, A; López-Chuliá, F; Lorenzo, I; Martínez, J; Martínez-Cuadrón, D; Montesinos, P; Navarro, I; Pemán, J; Rodríguez-Veiga, R; Salavert, M; Sanz, GF; Sanz, J; Sanz, MA1
Capilla, J; Guarro, J; Mayayo, E; Thomson, P1
Baculi, F; Bates, RJ; Bennett, B; Blease, K; Brown, H; Burnett, K; Celeridad, M; Chamberlain, P; Delgado, M; Ferguson, GD; Haelewyn, J; Hickman, M; Jackson, P; Jensen-Pergakes, K; LeBrun, L; Miyazawa, K; Nadolny, L; Nguyen, T; Packard, G; Pagarigan, B; Pierce, S; Plantevin-Krenitsky, V; Tang, Y; Tehrani, L; Torres, S; Xie, W; Xu, L1
Capilla, J; Guarro, J; Mayayo, E; Paredes, K1
Arnan, M; Duarte, RF; Pomares, H; Sánchez-Ortega, I; Sureda, A1
Bartlett, CH; Boer, K; Bondarenko, IM; Crown, JP; Ettl, J; Finn, RS; Huang, X; Kim, ST; Lang, I; Nadanaciva, S; Patel, R; Pinter, T; Randolph, S; Schmidt, M; Schnell, P; Slamon, DJ1
Blaeschke, F; Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Feucht, J; Feuchtinger, T; Handgretinger, R; Heinz, WJ; Klinker, H; Schwarze, CP1
Diéras, V; Finn, RS; Gauthier, E; Gelmon, K; Harbeck, N; Im, SA; Jones, S; Lipatov, ON; Lu, DR; Martin, M; Moulder, S; Randolph, S; Rugo, HS; Slamon, DJ; Walshe, JM1
Karthaus, M1
Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Rijnders, B; Span, LF; Stam, WB1
AbuTarif, M; Angulo, D; Cornely, OA; Krishna, G; Martinho, M; Xuan, F1
Edwards, JE; Gebremariam, T; Ibrahim, AS; Schwartz, JA; Spellberg, B1
Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K2
Denning, DW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA1
Collins, CD; Ellis, JJ; Kaul, DR1
Naeger-Murphy, N; Pile, JC1
Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W1
Maschmeyer, G1
Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J1
Barozzi, P; Forghieri, F; Luppi, M; Messino, M; Morselli, M; Pecorari, M; Potenza, L; Rossi, G; Rumpianesi, F; Torelli, G; Vallerini, D1
Hansel-Esteller, S; Selvy, N; Villiet, M1
Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A1
AbuTarif, MA; Krishna, G; Statkevich, P1
Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M1
Bocanegra, R; Graybill, JR; Najvar, LK; Patterson, TF; Wiederhold, NP1
Wingard, J1
Bouchara, JP; Chabasse, D; Hitoto, H; Pihet, M; Rachieru-Sourisseau, P; Weil, B1
Greiner, RA; Imhof, A; Meier, Y; O'Sullivan, AK; Papadopoulos, G1
Corey, M1
Odio, CM1
Colangelo, PM; Gobburu, JV; Jang, SH1
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS1
Lazzaro, C1
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A1
Dalakiouridou, M; Papaioannidou, P; Roilides, E; Saoulidis, S; Simitsopoulou, M; Walsh, TJ; Wheat, LJ1
Egerer, G; Geist, MJ1
Bryant, AM; Craig, M; Cumpston, A; Slain, D1
Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H1
Azim, S; Fadoo, Z; Manzoor, NF1
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC1
Chen, WT; Chen, YC; Hsiao, CH; Hsueh, PR; Ko, BS; Kuo, YM; Liu, JY; Yao, M1
Caira, M; Fianchi, L; Pagano, L; Valentini, CG1
Kurokawa, M; Masamoto, Y; Nannya, Y1
Brizio, A; Cantoni, S; Lombardi, G; Morra, E; Nosari, A; Riva, M1
Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L1
Amadloo, N; Ansari, M; Ashouri, Y; Hoseini, S; Mohammadianpanah, M; Mosalaei, A; Mosleh-Shirazi, MA; Nasrolahi, H; Omidvari, S; Tahmasebi, S; Talei, A1
Buckner, SL; Ceesay, MM; Flanagan, RJ; Morgan, PE; Pagliuca, A1
Alvarez, E; Calvo, E; Fothergill, AW; Guarro, J; Mayayo, E; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA1
Carreras, E; Casado, MA; de la Cámara, R; Grau, S; Jarque, I; Sabater, FJ; Sanz, MA1
Egerer, G1
Bartolesi, AM; Fanci, R; Pecile, P; Pini, G1
Caira, M; Cuenca-Estrella, M; Pagano, L1
Brisou, P; Darles, C; Gaillard, T; Pons, S; Roméo, E1
Menagé, Hdu P; Woolf, RT; Yeghen, T1
Cornely, OA; Heinz, WJ; Hertenstein, B; Horst, HA; Löffler, J; Maschmeyer, G; Requadt, C; Ruhnke, M; Wagner, T1
Cornely, OA; Karthaus, M; Ullmann, AJ1
Deplus, S; Dombret, H; Feuillhade, M; Fournier, S; Molina, JM; Pavageau, W; Verola, O; Zagdanski, AM1
Choquet, S; Chosidow, O; Consigny, S; Datry, A; Dhedin, N; Leblond, V1
Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L1
Andes, D; Conklin, R; Marchillo, K; Stamstad, T1
Jacobs, RF; Maples, HD; Saccente, SL; Stowe, CD1
Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Serena, C1
Sims-McCallum, RP1
Andes, D; Cacciapuoti, A; Conklin, R; Ezzet, F; Krishna, G; Loebenberg, D; Marchillo, K1
Candoni, A; Corvatta, L; D'Antonio, D; Del Favero, A; Fianchi, L; Girmenia, C; Martino, P; Nosari, A; Offidani, M; Pagano, L; Picardi, M1
Armstrong, D; Avila, NA; Bacher, J; Groll, AH; Hemmings, M; Lyman, CA; Mickiene, D; Peter, J; Petraitiene, R; Petraitis, V; Roussillon, K; Walsh, TJ1
Höhl, R1
Ausin, I; Badia, X; Carreras, E; Herrera, L; Roset, M1
Cordonnier, C1
Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK1
Buysschaert, I; De Laere, E; De Man, R; Demuynck, H; Ide, L; Surmont, I; Verlinde, A1
Afif, C; Bodey, GP; Boktour, MR; Chatzinikolaou, I; Cooksley, C; Hachem, RY; Kantarjian, HM; Kontoyiannis, DP; Perego, C; Raad, II1
Gavaldá, J; Lumbreras, C1
Klastersky, J1
Aebi, C; Aebischer, CC; Ammann, RA; Gugger, M; Jaton, K; Ritz, N; Schmid, RA1
Perfect, JR1
Bareau, B; Camus, C; Tattevin, P1
Danaher, PJ1
Lowry, CM; Marty, FM1
Oren, I1
Björkholm, M; Cherif, H; Chryssanthou, E; Kalin, M; Petrini, B1
Auvrignon, A; Boccon-Gibod, L; Landman-Parker, J; Leverger, G; Moissenet, D; Petit, A; Tabone, MD1
Chan-Tack, KM1
Colombo, GL; Morlotti, L; Serra, G1
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G1
Chamilos, G; Kontoyiannis, DP1
Burchardt, A; Corcoran, G; Cornely, OA; Courtney, R; Hachem, R; Kontoyiannis, DP; Krishna, G; Martinho, M; Raad, I; Töpelt, K; Ullmann, AJ; Wexler, D1
Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Dombrowski, F; Franke, A; Jentsch-Ullrich, K; Koenigsmann, M; Mohren, M; Schalk, E1
Anaissie, EJ; Dong, L; Gubbins, PO; Krishna, G; Martinho, M; Penzak, SR; Sansone-Parsons, A1
Colson, YL; Marty, FM; Paul, S1
Klastersky, J; Paesmans, M1
Aperis, G; Mylonakis, E; Spanakis, EK1
Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA1
Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ1
De Pauw, BE; Donnelly, JP1
Amoiridis, G; Kalmanti, M; Kondi, A; Mantadakis, E1
Collins, CD; DePestel, DD; Stevenson, JG; Stuntebeck, ER1
Almyroudis, NG; Ball, D; Bambach, BJ; Battiwalla, M; Gupta, S; Kwon-Chung, J; McCarthy, PL; Paplham, P; Proefrock, AD; Segal, BH; Varma, A1
Ho, DY; Lee, JD; Montoya, JG; Rosso, F1
Arisaka, O; Fujisawa, M; Fukushima, K; Hagisawa, S; Kurosawa, H; Matsunaga, T; Nakajima, D; Sugita, K1
Collins, CD; DePestel, DD; Erba, HP; Mackler, ER; Shehab, N; Welch, K1
Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C1
Bongiovanni, M; Chalandon, Y; Meyer, M; Pache, JC; Van Delden, C; Waldvogel, S1
Jarque, I; Sanz, MA1
Blaich, A; Hopt, UT; Kaffarnik, M; Utzolino, S1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA1
Buadi, FK; McClune, B; Przepiorka, D1
Hogan, H; Howell, A; Lewis, R; Safdar, A1
Almyroudis, NG; Gonzalez, AV; Segal, BH; Ullmann, AJ1
Anaissie, E; Buvé, K; Maertens, J1
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J1
Anaissie, EJ; Uzun, O1
Hachem, R; Raad, I1
Anaissie, EJ; Dignani, MC; Karyotakis, NC1
Björkholm, M1
Chanock, SJ; Walsh, TJ1
Denning, DW; Morrissey, G; Oakley, KL1
Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O1
Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H1
Hoban, DJ; Karlowsky, JA; Zhanel, GG1
de Pauw, BE; Kullberg, BJ1
MacDonald, J; Rawlins, S1
Avila, N; Bacher, J; Candelario, M; Field-Ridley, A; Groll, AH; Petraitiene, R; Petraitis, V; Piscitelli, S; Sein, T; Walsh, TJ1
Hayashi, R; Ichikawa, T; Iizawa, Y; Itoh, K; Kitamoto, N; Kitazaki, T; Okonogi, K1
Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S1
Marr, KA1
Dixon, CA; Goldberger, MJ; Powers, JH1
De Roux, A; Grassot, A; Grysczyk, H; Lode, H; Mauch, H1
Dismukes, WE; Lee, J; Walsh, TJ1
Johnson, JR1
Apisarnthanarak, A; Little, JR; Tebas, P1
Cornely, OA; Heussel, CP; Ullmann, AJ1
Mattie, H; van Furth, R; Van t Wout, JW1

Reviews

35 review(s) available for triazoles and Neutropenia

ArticleYear
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
    Mycopathologia, 2020, Volume: 185, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole

2020
Breakthrough invasive fungal infections: Who is at risk?
    Mycoses, 2020, Volume: 63, Issue:10

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillus; Candida; Central Venous Catheters; Echinocandins; Fluconazole; Fusarium; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Mucorales; Mycoses; Neutropenia; Opportunistic Infections; Organ Transplantation; Penicillium; Risk Factors; Triazoles

2020
FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
    The oncologist, 2021, Volume: 26, Issue:10

    Topics: Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Multicenter Studies as Topic; Neutropenia; Treatment Outcome; Triazoles

2021
Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Adolescent; Adult; Antifungal Agents; Child; Echinocandins; Female; Humans; Leukemia; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Triazoles

2017
Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Invasive Fungal Infections; Network Meta-Analysis; Neutropenia; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles

2018
Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.
    Annals of hematology, 2013, Volume: 92, Issue:6

    Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Multicenter Studies as Topic; Mycoses; Neutropenia; Odds Ratio; Patient Dropouts; Prospective Studies; Randomized Controlled Trials as Topic; Transplantation Conditioning; Treatment Outcome; Triazoles

2013
Treatment of fungal disease in the setting of neutropenia.
    Hematology. American Society of Hematology. Education Program, 2013, Volume: 2013

    Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2014, Feb-24, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2014
Clinical indications for newer antifungal agents.
    Journal of hospital medicine, 2009, Volume: 4, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Drug Therapy; Echinocandins; Endemic Diseases; Humans; Mycoses; Neutropenia; Triazoles; Zygomycosis

2009
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63 Suppl 1

    Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole

2009
Modern antifungal therapy for neutropenic fever.
    Current hematologic malignancy reports, 2006, Volume: 1, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2006
[Antifungal therapy for infants, children and adolescents with suspected or documented invasive fungal infection].
    Drugs of today (Barcelona, Spain : 1998), 2010, Volume: 46 Suppl C

    Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Candidiasis; Child; Child, Preschool; Fever; Humans; Infant; Infant, Newborn; Mycoses; Neoplasms; Neutropenia; Triazoles

2010
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Adult; Alemtuzumab; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Combined Modality Therapy; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fusariosis; Fusarium; Granulocytes; Humans; Immunocompromised Host; Leukocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole

2011
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2011
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.
    Blood, 2003, May-01, Volume: 101, Issue:9

    Topics: Adrenal Cortex Hormones; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Clinical Trials as Topic; Disease Susceptibility; Drug Carriers; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Liposomes; Mycoses; Neutropenia; Recurrence; Risk Factors; Triazoles

2003
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:12

    Topics: Antifungal Agents; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Trichosporon; Voriconazole

2002
Mucormycosis in hematologic patients.
    Haematologica, 2004, Volume: 89, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Encephalitis; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Italy; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Retrospective Studies; Risk Factors; Sinusitis; Treatment Outcome; Triazoles

2004
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients].
    Mycoses, 2003, Volume: 46 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive Care Units; Lipopeptides; Lung Diseases, Fungal; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2003
[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].
    Medicina clinica, 2004, May-01, Volume: 122, Issue:16

    Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fever; Humans; Liposomes; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2004
Fungal infections: current diagnosis and treatment.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Fungemia; Humans; Immunocompromised Host; Mycoses; Neoplasms; Neutropenia; Premedication; Randomized Controlled Trials as Topic; Risk Factors; Triazoles

2004
[Invasive aspergillosis: clinical manifestations and treatment].
    Revista iberoamericana de micologia, 2003, Volume: 20, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole

2003
Management of invasive mycoses in hematology patients: current approaches.
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Hematopoietic Stem Cell Transplantation; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides, Cyclic; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles

2004
Voriconazole versus amphotericin B in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
Zygomycoses in patients with acute leukaemia.
    Annals of hematology, 2006, Volume: 85, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Female; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2006
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:2

    Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fever; Hematologic Neoplasms; Humans; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Mycoses, 2007, Volume: 50, Issue:3

    Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
    Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:8

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fever; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2007
[Current indications for voriconazole in onco-hematological patients].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis

2007
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:2

    Topics: Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Myelodysplastic Syndromes; Neoplasms; Neutropenia; Risk Assessment; Triazoles

2008
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:2

    Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Enzyme-Linked Immunosorbent Assay; Humans; Immunocompromised Host; Mycoses; Neoplasms; Neutropenia; Proteoglycans; Risk Assessment; Tomography, X-Ray Computed; Triazoles

2008
Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal.
    Blood, 1995, Sep-15, Volume: 86, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Drug Administration Routes; Hematopoietic Cell Growth Factors; Humans; Immunocompromised Host; Leukocyte Transfusion; Mycoses; Neoplasms; Neutropenia; Triazoles

1995
Chemoprophylaxis of fungal infections in neutropenic patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7

    Topics: Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Neutropenia; Polyenes; Triazoles

1994
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
    Bone marrow transplantation, 1996, Volume: 18 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles

1996
Therapy of invasive fungal infections.
    The Netherlands journal of medicine, 1999, Volume: 55, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Contraindications; Drug Therapy, Combination; Flucytosine; Fungemia; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Mycoses; Neutropenia; Triazoles

1999

Trials

23 trial(s) available for triazoles and Neutropenia

ArticleYear
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
    The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Aspergillus; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neutropenia; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2018
Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study.
    The Journal of infection, 2018, Volume: 77, Issue:3

    Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Humans; Incidence; Leukemia; Male; Micafungin; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Survival Analysis; Treatment Failure; Triazoles

2018
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.
    PloS one, 2019, Volume: 14, Issue:3

    Topics: Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Antineoplastic Agents; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunocompromised Host; Infant; Invasive Fungal Infections; Male; Neoplasms; Neutropenia; Prospective Studies; Triazoles

2019
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
    European journal of haematology, 2014, Volume: 93, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Echinocandins; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Triazoles

2014
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Antifungal Agents; Female; Humans; Male; Middle Aged; Mycoses; Neutropenia; Tablets; Triazoles

2014
Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Nitriles; Patient Safety; Pyridines; Triazoles

2015
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
    Breast cancer research : BCR, 2016, 06-28, Volume: 18, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neutropenia; Nitriles; Piperazines; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Retreatment; Survival Analysis; Treatment Outcome; Triazoles

2016
Palbociclib and Letrozole in Advanced Breast Cancer.
    The New England journal of medicine, 2016, 11-17, Volume: 375, Issue:20

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclin-Dependent Kinases; Disease-Free Survival; Double-Blind Method; Female; Humans; Letrozole; Middle Aged; Neutropenia; Nitriles; Piperazines; Postmenopause; Protein Kinase Inhibitors; Pyridines; Receptors, Estrogen; Triazoles

2016
Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
    Pharmacotherapy, 2008, Volume: 28, Issue:10

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Prospective Studies; Single-Blind Method; Triazoles; Young Adult

2008
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:1

    Topics: Amphotericin B; Australia; Cost-Benefit Analysis; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
    European journal of haematology, 2010, Volume: 84, Issue:3

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult

2010
Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
    Current medical research and opinion, 2010, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Population; Single-Blind Method; Triazoles; Young Adult

2010
Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma.
    Clinical pharmacology and therapeutics, 2010, Volume: 88, Issue:1

    Topics: Antifungal Agents; Antineoplastic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Graft vs Host Disease; Humans; Mycoses; Neutropenia; Stem Cell Transplantation; Treatment Outcome; Triazoles

2010
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles

2010
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2011
Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.
    Mycoses, 2012, Volume: 55, Issue:3

    Topics: Antifungal Agents; Australia; Caspofungin; Echinocandins; Economics, Pharmaceutical; Fever; Humans; Lipopeptides; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2012
The efficacy and safety of neoadjuvant chemotherapy +/- letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial.
    Breast cancer research and treatment, 2012, Volume: 132, Issue:3

    Topics: Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Letrozole; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Nitriles; Postmenopause; Statistics, Nonparametric; Treatment Outcome; Triazoles; Tumor Burden

2012
Measurement of posaconazole, itraconazole, and hydroxyitraconazole in plasma/serum by high-performance liquid chromatography with fluorescence detection.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Cohort Studies; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Limit of Detection; Male; Middle Aged; Neutropenia; Reproducibility of Results; Spectrometry, Fluorescence; Triazoles; Young Adult

2011
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Placebos; Pyrimidines; Triazoles; Voriconazole

2013
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Female; Fever; Humans; Male; Middle Aged; Mycoses; Neutropenia; Triazoles

2006
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles

2007
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Leukemia, 2008, Volume: 22, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2008
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2002

Other Studies

107 other study(ies) available for triazoles and Neutropenia

ArticleYear
Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
    International journal of hematology, 2017, Volume: 106, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Central Venous Catheters; Child; Child, Preschool; Consolidation Chemotherapy; Female; Humans; Incidence; Induction Chemotherapy; Infant; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Retrospective Studies; Risk Factors; Serum Albumin; Sex Factors; Triazoles; Young Adult

2017
Efficacy and safety of posaconazole in hematopoietic stem cell transplantation patients with invasive fungal disease.
    Future microbiology, 2017, Volume: 12

    Topics: Adult; Antifungal Agents; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Multivariate Analysis; Neutropenia; Primary Prevention; Regression Analysis; Retrospective Studies; Steroids; Time Factors; Transplantation Conditioning; Treatment Outcome; Triazoles

2017
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
    Mycoses, 2018, Volume: 61, Issue:3

    Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2018
Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in Greece.
    Journal of medical economics, 2013, Volume: 16, Issue:5

    Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Greece; Health Expenditures; Humans; Immunocompromised Host; Itraconazole; Models, Economic; Mycoses; Neutropenia; Triazoles

2013
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    American journal of hematology, 2013, Volume: 88, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole

2013
Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2013, Volume: 26, Issue:1

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Candidiasis, Invasive; Child; Child, Preschool; Combined Modality Therapy; Cross Infection; Drug Evaluation; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Postoperative Complications; Retrospective Studies; Risk; Transplantation, Homologous; Treatment Outcome; Triazoles; Young Adult

2013
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:2

    Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Invasive mucormycosis without radiological alterations.
    Blood, 2013, Aug-08, Volume: 122, Issue:6

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Female; Fungi; Humans; Liposomes; Mucormycosis; Neutropenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Stem Cell Transplantation; Tomography, X-Ray Computed; Triazoles

2013
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
    Mycopathologia, 2014, Volume: 177, Issue:1-2

    Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole

2014
Host biomarkers of invasive pulmonary aspergillosis to monitor therapeutic response.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Amphotericin B; Animals; Annexin A1; Antifungal Agents; Aspergillus fumigatus; Biomarkers; Bronchoalveolar Lavage Fluid; C-Reactive Protein; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Humans; Invasive Pulmonary Aspergillosis; Neutropenia; Proteomics; Rabbits; Thiazoles; Triazoles

2014
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
    Clinical drug investigation, 2014, Volume: 34, Issue:7

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Quality of Life; Quality-Adjusted Life Years; Sweden; Triazoles

2014
Membrane active vancomycin analogues: a strategy to combat bacterial resistance.
    Journal of medicinal chemistry, 2014, Jun-12, Volume: 57, Issue:11

    Topics: Animals; Bacteremia; Cell Membrane Permeability; Drug Resistance, Bacterial; Enterococcus; Female; HeLa Cells; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Neutropenia; Quaternary Ammonium Compounds; Staphylococcal Infections; Staphylococcus; Structure-Activity Relationship; Triazoles; Vancomycin

2014
Review: voriconazole for prevention or treatment of invasive fungal infections in cancer with neutropenia.
    Annals of internal medicine, 2014, Jul-15, Volume: 161, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Humans; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles

2014
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Benzoates; Caspofungin; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mucormycosis; Neutropenia; Rhizopus; Treatment Outcome; Triazoles

2014
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:6

    Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Incidence; Infant; Itraconazole; Male; Mycoses; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Triazoles

2015
Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Antifungal Agents; China; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Mycoses; Myeloablative Agonists; Neutropenia; Prognosis; Prospective Studies; Risk Factors; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Triazoles; Unrelated Donors

2015
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
    Bone marrow transplantation, 2015, Volume: 50, Issue:11

    Topics: Administration, Oral; Adult; Aged; Allografts; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cause of Death; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Lipopeptides; Male; Medication Adherence; Middle Aged; Mycoses; Neutropenia; Patient Compliance; Premedication; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Failure; Triazoles; Young Adult

2015
Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Animals; Antifungal Agents; Basidiomycota; beta-Glucans; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Immunocompromised Host; Kidney; Male; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Neutropenia; Proteoglycans; Triazoles

2015
A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: Animals; Arthritis, Experimental; Basophils; Cell Line; Collagen; Crystallography, X-Ray; Dose-Response Relationship, Drug; Edema; Eosinophils; Female; HEK293 Cells; Humans; Hypertension; Indazoles; Inflammation; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Male; Neutropenia; Neutrophils; Protein-Tyrosine Kinases; Pyridines; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Receptors, Fc; Skin; Syk Kinase; Triazoles; Vascular Endothelial Growth Factor Receptor-2

2016
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole

2016
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
    Mycoses, 2016, Volume: 59, Issue:8

    Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic-Myeloproliferative Diseases; Neutropenia; Numbers Needed To Treat; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Triazoles

2016
Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia.
    Medical mycology, 2017, Jun-01, Volume: 55, Issue:4

    Topics: Adolescent; Age Factors; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neutropenia; Plasma; Retrospective Studies; Sex Factors; Triazoles

2017
Treatment of aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Aug-01, Volume: 47, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neutropenia; Triazoles

2008
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
    European journal of haematology, 2008, Volume: 81, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Costs and Cost Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Netherlands; Neutropenia; Randomized Controlled Trials as Topic; Triazoles

2008
Posaconazole mono- or combination therapy for treatment of murine zygomycosis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Diabetic Ketoacidosis; Dose-Response Relationship, Drug; Drug Combinations; Kidney; Liposomes; Male; Mice; Mice, Inbred BALB C; Neutropenia; Rhizopus; Triazoles; Zygomycosis

2009
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:1

    Topics: Animals; Antifungal Agents; Brain; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluconazole; Kidney; Male; Mice; Neutropenia; Nitriles; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Dec-01, Volume: 65, Issue:23

    Topics: Antifungal Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Monte Carlo Method; Multicenter Studies as Topic; Mycoses; Neutropenia; Triazoles

2008
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole

2009
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole

2009
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
    American journal of hematology, 2010, Volume: 85, Issue:3

    Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Caspofungin; Combined Modality Therapy; Echinocandins; Humans; Hyphae; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Leukemia, B-Cell; Lipopeptides; Male; Middle Aged; Neutropenia; Spleen; Splenectomy; Splenic Diseases; Triazoles

2010
[Prophylaxis use of posaconazole (P) in an hemato-oncology unit: a retrospective study].
    Pathologie-biologie, 2010, Volume: 58, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Therapy, Combination; Esomeprazole; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Service, Hospital; Postoperative Complications; Premedication; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Triazoles

2010
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2010
Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Animals; Antifungal Agents; Chemoprevention; Disease Models, Animal; Drug Resistance, Fungal; Fusarium; Humans; Kidney; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Neutropenia; Treatment Outcome; Triazoles

2010
Antifungal management.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Cord Blood Stem Cell Transplantation; Echinocandins; Humans; Leukemia; Lung; Male; Middle Aged; Neutropenia; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.
    Mycopathologia, 2010, Volume: 170, Issue:3

    Topics: Acremonium; Amphotericin B; Antifungal Agents; Blood; Child; Fever; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2010
Cost-effectiveness of posaconazole compared with standard azole therapy for prevention of invasive fungal infections in patients at high risk in Switzerland.
    Oncology, 2010, Volume: 78, Issue:3-4

    Topics: Cost-Benefit Analysis; Decision Support Techniques; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Markov Chains; Models, Theoretical; Mycoses; Myelodysplastic Syndromes; Neutropenia; Risk; Switzerland; Treatment Outcome; Triazoles

2010
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
    Pediatric hematology and oncology, 2010, Volume: 27, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2010
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
    Bone marrow transplantation, 2011, Volume: 46, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2011
Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model.
    Mycoses, 2011, Volume: 54, Issue:5

    Topics: Animal Structures; Animals; Colony Count, Microbial; Disease Models, Animal; Granulocyte Colony-Stimulating Factor; Humans; Male; Mice; Mice, Inbred BALB C; Neutropenia; Rhizopus; Rodent Diseases; Treatment Outcome; Triazoles; Zygomycosis

2011
Posaconazole prophylaxis in patients with acute myelogenous leukaemia--results from an observational study.
    Mycoses, 2011, Volume: 54 Suppl 1

    Topics: Adult; Aged; Antifungal Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Retrospective Studies; Triazoles

2011
A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies; Triazoles

2011
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
    International journal of hematology, 2011, Volume: 93, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole

2011
Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
    JPMA. The Journal of the Pakistan Medical Association, 2010, Volume: 60, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Fever; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
Voriconazole is effective as secondary antifungal prophylaxis in leukemia patients with prior pulmonary fungal disease: case series and review of literature.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1

    Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Female; Humans; Leukemia; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Oral voriconazole for neutropenia: a leukemia patient with probable pulmonary aspergillosis and scedosporidiosis.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1

    Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Leukemia; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2011
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole

2011
In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Disease Models, Animal; Drug Resistance, Fungal; Kidney; Male; Mice; Microbial Sensitivity Tests; Mucor; Mucormycosis; Neutropenia; Species Specificity; Survival Rate; Treatment Failure; Triazoles

2012
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.
    BMC infectious diseases, 2012, Apr-03, Volume: 12

    Topics: Antifungal Agents; Chemoprevention; Cost-Benefit Analysis; Hematologic Neoplasms; Humans; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Prospective Studies; Spain; Triazoles

2012
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
    Mycoses, 2012, Volume: 55 Suppl 2

    Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole

2012
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
    Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole

2013
The management of febrile neutropenia in the posaconazole era: a new challenge?
    Haematologica, 2012, Volume: 97, Issue:7

    Topics: Antifungal Agents; Antineoplastic Agents; Fever; Fungi; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mannans; Mycoses; Neutropenia; Polymerase Chain Reaction; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles

2012
[Disseminated infection due to Geotrichum capitatum].
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Geotrichosis; Geotrichum; Granuloma; Hepatitis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Male; Neutropenia; Opportunistic Infections; Sepsis; Triazoles

2012
A rash in a patient with neutropenia.
    BMJ (Clinical research ed.), 2012, Dec-13, Volume: 345

    Topics: Aged; Antifungal Agents; Dermatomycoses; Fever; Fusariosis; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Triazoles

2012
Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jul-15, Volume: 37, Issue:2

    Topics: Aged; Amphotericin B; Antifungal Agents; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:11

    Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2003
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10

    Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Kidney; Mice; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2003
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:11

    Topics: Antifungal Agents; Fatal Outcome; Humans; Infant; Mycoses; Neutropenia; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2003
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:12

    Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Scedosporium; Spleen; Survival Analysis; Triazoles; Voriconazole

2003
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Nov-15, Volume: 60, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:1

    Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Triazoles

2004
Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Dose-Response Relationship, Drug; Female; Galactose; Half-Life; Image Processing, Computer-Assisted; Immunosuppressive Agents; Injections, Intravenous; Lung; Mannans; Microbial Sensitivity Tests; Neutropenia; Rabbits; Survival Analysis; Tetrazolium Salts; Thiazoles; Tomography, X-Ray Computed; Triazoles

2004
Alternatives to amphotericin B for Candida rugosa infection.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole

2004
Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:9

    Topics: Antifungal Agents; Aspergillosis; Humans; Neutropenia; Triazoles; Zygomycosis

2004
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
    Cancer, 2004, Oct-01, Volume: 101, Issue:7

    Topics: Adult; Aged; Amphotericin B; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cross Infection; Drug Resistance, Fungal; Female; Humans; Leukemia; Male; Middle Aged; Neutropenia; Opportunistic Infections; Retrospective Studies; Risk Factors; Triazoles

2004
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
    The New England journal of medicine, 2004, Sep-30, Volume: 351, Issue:14

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child.
    European journal of pediatrics, 2005, Volume: 164, Issue:4

    Topics: Absidia; Antifungal Agents; Child; Drug Resistance, Fungal; Female; Humans; Neutropenia; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2005
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Triazoles

2005
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole

2005
Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Mar-01, Volume: 40, Issue:5

    Topics: Aged; Antifungal Agents; Fever; Humans; Mucormycosis; Neutropenia; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2005
Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies.
    Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:11-12

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fungi; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Triazoles

2004
[Disseminated fusarium infection in two neutropenic children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Child; Drug Combinations; Fatal Outcome; Female; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2005
Fatal Trichosporon asahii septicemia in a Guatemalan farmer with acute lymphoblastic leukemia.
    Southern medical journal, 2005, Volume: 98, Issue:9

    Topics: Adult; Agriculture; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Peripheral; Emigration and Immigration; Fatal Outcome; Fever; Guatemala; Humans; Male; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Trichosporon; United States; Urease; Voriconazole; Yeasts

2005
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
    Recenti progressi in medicina, 2005, Volume: 96, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
    Haematologica, 2005, Volume: 90 Suppl

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole

2005
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
    The Journal of infection, 2005, Volume: 51, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2005
Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Antifungal Agents; Area Under Curve; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Mucositis; Neutropenia; Severity of Illness Index; Stem Cell Transplantation; Triazoles

2006
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
    The Annals of thoracic surgery, 2006, Volume: 82, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis

2006
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2006
Prophylaxis and aspergillosis--has the principle been proven?
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles

2007
Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Demyelinating Diseases; Electromyography; Fever; Humans; Lung Diseases; Male; Neural Conduction; Neurotoxicity Syndromes; Neutropenia; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Triazoles; Vincristine

2007
Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia.
    Clinical drug investigation, 2007, Volume: 27, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Decision Support Techniques; Economics, Pharmaceutical; Fever; Health Care Costs; Humans; Liposomes; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2007
Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:2

    Topics: Adolescent; Antifungal Agents; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mycoses; Neutropenia; Triazoles

2007
[Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Infant; Leukemia; Male; Metabolic Clearance Rate; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2007
Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Pharmacotherapy, 2007, Volume: 27, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Female; Fever; Health Care Costs; Hospitalization; Humans; Male; Middle Aged; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    BMC infectious diseases, 2007, Jul-02, Volume: 7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
    Mycoses, 2008, Volume: 51, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Combinations; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Triazoles; Voriconazole

2008
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Pharmacotherapy, 2008, Volume: 28, Issue:1

    Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Bilirubin; Creatinine; Exanthema; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2008
Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:1

    Topics: Adult; Biological Availability; Fusarium; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunocompromised Host; Interferon-gamma; Leukemia; Male; Mycoses; Neutropenia; Recombinant Proteins; Salvage Therapy; Treatment Outcome; Triazoles

2008
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10

    Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole

2008
Treatment of central venous catheter-related fungemia due to Fusarium oxysporum.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20, Issue:3

    Topics: Catheterization, Central Venous; Fever; Fungemia; Fusarium; Humans; Male; Middle Aged; Neutropenia; Triazoles

1995
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred Strains; Neutropenia; Triazoles

1995
Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:7

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Microbial; Itraconazole; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Neutropenia; Survival Rate; Time Factors; Triazoles

1997
[Rare pulmonary mycoses in patients with hematologic diseases].
    Revue de pneumologie clinique, 1998, Volume: 54, Issue:5

    Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole

1998
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Fluconazole; Guinea Pigs; Male; Neutropenia; Pyrimidines; Random Allocation; Triazoles; Voriconazole

1999
In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:6

    Topics: Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole

1999
Neurtropenia due to nefazodone, interaction or coincidence?
    The Australian and New Zealand journal of psychiatry, 2000, Volume: 34, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Neutropenia; Piperazines; Triazoles

2000
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:3

    Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Galactose; Itraconazole; Lung Diseases, Fungal; Mannans; Neutropenia; Rabbits; Treatment Outcome; Triazoles

2001
Efficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary Aspergillosis in neutropenic mice.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2

    Topics: Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Disease Models, Animal; Female; Imidazoles; Injections, Intravenous; Mice; Mice, Inbred CBA; Neutropenia; Tetrazoles; Treatment Outcome; Triazoles

2002
Empirical antifungal therapy--new options, new tradeoffs.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Treatment Outcome; Triazoles; Voriconazole

2002
[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
    Deutsche medizinische Wochenschrift (1946), 2002, Mar-08, Volume: 127, Issue:10

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Male; Middle Aged; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2002
Decisions about voriconazole versus liposomal amphotericin B.
    The New England journal of medicine, 2002, May-09, Volume: 346, Issue:19

    Topics: Amphotericin B; Antifungal Agents; Clinical Protocols; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fever; Humans; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:2

    Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles

1989